Association between antihypertensive drugs and oral cancer: a drug target Mendelian randomization study
Background: Recent reports have suggested that antihypertensive drugs may play an oncogenic role in common cancers, but it is still uncertain whether this could influence the risk of oral cancer. Through two-sample Mendelian randomization (MR), we sought to assess the causal effect of antihypertensi...
Main Authors: | Junfeng Guo, Rongxing Liu, Fangfang Sheng, Qiuxiang Wu, Rufu Xu, Haitao He, Gang Zhang, Junjie Huang, Zhe Zhang, Rong Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1294297/full |
Similar Items
-
Association of antihypertensive drugs with fracture and bone mineral density: A comprehensive drug-target Mendelian randomization study
by: Xin Huang, et al.
Published: (2023-03-01) -
Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations
by: Bohan Fan, et al.
Published: (2024-01-01) -
Genetically predicted hypertension, antihypertensive drugs, and risk of erectile dysfunction: a Mendelian randomization study
by: Cong Zhao, et al.
Published: (2023-06-01) -
Hypertension, antihypertensive drugs, and age at onset of Huntington’s disease
by: Yahui Zhu, et al.
Published: (2023-05-01) -
Protective effect of antihypertensive drugs on the risk of Parkinson’s disease lacks causal evidence from mendelian randomization
by: Zheng Jiang, et al.
Published: (2023-02-01)